Taccari Francesco, Buonsenso Danilo
UOC Malattie Infettive, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Infectious Diseases Consultant, Gemelli Molise Hospital, Campobasso, Italy.
J Ultrasound Med. 2021 May;40(5):1037-1038. doi: 10.1002/jum.15468. Epub 2020 Aug 24.
During the COVID-19 pandemic Lung Ultrasound (LUS) has clearly succeeded as a formidable tool in the management of SARS-CoV-2 infection. A multitude of scientific papers, webinars and social media discussions has celebrated LUS benefits in the last few months, more than ever. LUS is based on the interpretation of artifacts, and different combinations of basic LUS artifacts can detect different pathologies. We discuss the need to identify new artifacts for new diseases.
在新冠疫情期间,肺部超声(LUS)已明确成为管理新型冠状病毒2(SARS-CoV-2)感染的一项强大工具。在过去几个月里,众多科学论文、网络研讨会和社交媒体讨论都前所未有地颂扬了LUS的益处。LUS基于对伪像的解读,基本LUS伪像的不同组合可检测出不同的病理情况。我们讨论了为新疾病识别新伪像的必要性。